Welcome to HemaCare Corporation – a leading global provider of biological blood products and services since 1978.
Since 1978, HemaCare Bioresearch Products and Services has been the trusted research partner of choice from concept to commercialization. Built on a 36-year history in apheresis collection, HemaCare is a leader in Cell and Tissue Collection, Processing and Cell Therapy, providing the high-quality biological material derived from normal and mobilized peripheral blood, bone marrow and cord blood needed to ensure quality research outcomes that meet the unique needs of the scientific community. Learn more or view our Company Overview Presentation.
HemaCare provides a variety of quality, controlled, consistent, viable human primary cells and blood components derived from an assortment of tissues. Our cell processing lab is capable of purifying lymphocytes, monocytes, neutrophils, CD34+ stem cells, and much more!
Quality of living cellular raw material is a major determinant of final product characteristics. Controlling and qualifying the cell collection step is essential to minimizing operational sources of variability, and greatly increases the likelihood of success in manufacturing. HemaCare’s specialty is apheresis collection, and, building on over 35 years of experience, has addressed this need for optimized cell collection with a program for controlling and qualifying its apheresis procedures and collection sites, bringing a higher degree of reproducibility to research projects or manufacturing efforts based on cGMP and cGTP principles.
THERAPEUTIC APHERESIS SAMPLE ORDER FORMS
Mon, 06 Jul 2015 20:00:31 +0000
Wed, 01 Jul 2015 20:00:38 +0000
Mon, 29 Jun 2015 20:00:36 +0000
Wed, 24 Jun 2015 20:00:06 +0000
Mon, 22 Jun 2015 20:00:31 +0000
Wed, 17 Jun 2015 20:00:40 +0000
Mon, 15 Jun 2015 20:00:55 +0000
Wed, 10 Jun 2015 20:00:50 +0000
Mon, 08 Jun 2015 20:00:28 +0000
Wed, 03 Jun 2015 20:00:02 +0000
E-NEWSLETTER SIGN UP